Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

FREEMAN NEOSHO HOSPITAL

NPI: 1598873796 · NEOSHO, MO 64850 · Critical Access Hospital · NPI assigned 08/28/2006

$6.06M
Total Medicaid Paid
54,224
Total Claims
51,177
Beneficiaries
51
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialGRADDY, STEVE (CFO)
NPI Enumeration Date08/28/2006

Related Entities

Other providers sharing the same authorized official: GRADDY, STEVE

ProviderCityStateTotal Paid
FREEMAN-OAK HILL HEALTH SYSTEM JOPLIN MO $14.73M
FREEMAN-OAK HILL HEALTH SYSTEM ANDERSON MO $1.01M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 8,829 $1.39M
2019 6,154 $1.09M
2020 3,652 $492K
2021 6,392 $231K
2022 9,115 $734K
2023 12,333 $1.19M
2024 7,749 $934K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
X4011 State-specific procedure code 7,215 7,017 $1.80M
99283 Emergency department visit for the evaluation and management, moderate severity 6,750 6,519 $1.22M
99284 Emergency department visit for the evaluation and management, high severity 3,488 3,276 $882K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,100 999 $372K
80053 Comprehensive metabolic panel 6,382 5,965 $344K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 7,395 6,832 $333K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2,277 2,244 $263K
81001 4,207 3,982 $226K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1,301 1,258 $196K
87400 481 451 $88K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1,314 1,243 $64K
J3490 Unclassified drugs 3,400 2,945 $50K
71046 Radiologic examination, chest; 2 views 383 373 $33K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 307 300 $28K
71045 Radiologic examination, chest; single view 337 315 $21K
87081 210 205 $20K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 738 684 $14K
96375 Therapeutic injection; each additional sequential IV push 237 224 $13K
99282 Emergency department visit for the evaluation and management, low to moderate severity 117 115 $12K
83655 1,009 993 $10K
99281 Emergency department visit for the evaluation and management, self-limited or minor 138 136 $10K
84484 620 554 $7K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 275 266 $7K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 117 114 $6K
82550 645 591 $4K
82553 404 376 $4K
87420 27 27 $4K
84703 315 305 $3K
96361 Intravenous infusion, hydration; each additional hour 50 50 $3K
84443 Thyroid stimulating hormone (TSH) 341 341 $3K
83690 508 491 $3K
87428 88 88 $2K
80061 Lipid panel 246 245 $2K
84145 105 102 $2K
81002 484 370 $2K
83605 180 168 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 17 17 $1K
85018 247 244 $1K
80048 Basic metabolic panel (calcium, ionized) 155 149 $1K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 12 12 $987.04
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 137 134 $900.00
80306 48 47 $727.85
83036 Hemoglobin; glycosylated (A1C) 37 37 $282.98
36415 Collection of venous blood by venipuncture 27 26 $232.50
85730 37 37 $152.62
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 197 191 $144.15
85610 37 37 $108.96
81003 12 12 $26.94
85027 29 29 $13.32
84439 12 12 $11.37
85007 29 29 $7.83